β-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction Review uri icon

Overview

MeSH Major

  • Adrenergic beta-Antagonists
  • Cardiovascular Agents
  • Depression
  • Fatigue
  • Sexual Dysfunction, Physiological

abstract

  • The conventional wisdom that beta-blocker therapy is associated with substantial risks of depressive symptoms, fatigue, and sexual dysfunction is not supported by data from clinical trials. There is no significant increased risk of depressive symptoms and only small increased risks of fatigue and sexual dysfunction. The risks of these adverse effects should be put in the context of the documented benefits of these medications.

publication date

  • July 17, 2002

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 12117400

Additional Document Info

start page

  • 351

end page

  • 7

volume

  • 288

number

  • 3